Alere has received a clinical laboratory improvement amendments (CLIA) waiver from the US Food and Drug Administration (FDA) for its influenza A&B test.

The Alere influenza A&B test, which collects samples through a minimally invasive nasal swab method, utilises highly sensitive antibodies to detect influenza type A and B antigens. The test provides accurate, reliable and timely patient results, wherever they are performed.

The company said the new Alere test, when compared to the viral culture, showed performance with sensitivity / specificity of 93.8% / 95.8% for flu A and 77.4% / 98% for flu B. The highly sensitive rapid test provides results in ten minutes, making it possible for physicians to administer treatment while patients are still in their care.

The Alere influenza A&B test also adds a dipstick format test to Alere’s existing portfolio of influenza diagnostics, which includes the card format BinaxNOW influenza A&B Test, helping the company to provide primary care physicians with a full range of easy-to-use, effective tools for identifying influenza A and B at the point of care.

Alere Infectious Disease vice-president Avi Pelossof said that by getting this product into the waived segment of the marketplace, they are giving healthcare providers a new tool that will enable them to make better decisions about flu diagnosis and treatment while patients are still in the office.

Alere develops new capabilities in near-patient diagnosis, monitoring and health management, which helps individuals to take charge of improving their health and quality of life at home. The company’s products and services, as well as its new product development efforts, focus on cardiology, women’s health, infectious disease, oncology and toxicology.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.